Maximo F. Nougues, Chief Financial Officer at PUMA BIOTECHNOLOGY, INC. (PBYI), sold 9,522 shares at $3.53 ($34K) on 2025-07-08, disclosed to the SEC on 2025-07-10.
Scheduled sale ($34k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.53 | 5,587 | $20K | 58.6% |
| 2 | $3.54 | 3,935 | $14K | 41.4% |
| Total | $3.53 avg | 9,522 | $34K | 100% |
| Filing → |
| PBYI | SELL | 2025-01-03 | $32K | — | Filing → |
| PBYI | SELL | 2024-07-18 | $15K | — | Filing → |
| PBYI | SELL | 2024-07-02 | $17K | — | Filing → |